Publications by authors named "Brian Meissner"

Claim this Profile
A
Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of CYP2D6 phenotype on metabolic abnormalities.
Brian R Meissner, Fatme Younes, Amanda Massmann, Max Weaver, Natasha Petry

Am J Health Syst Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34 cells derived from diabetic older adults.
Jesmin Jahan, Ildamaris Monte de Oca, Brian Meissner, Shrinidh Joshi, Ahmad Maghrabi

Eur J Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a co-pay accumulator adjustment program on specialty drug adherence.
Bruce W Sherman, Andrew J Epstein, Brian Meissner, Manish Mittal

Am J Manag Care· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.
JaeJin An, Fang Niu, Daniel T Lang, Kristin P Jazdzewski, Paul T Le, Brian Meissner

J Am Heart Assoc· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting.
Brian Meissner, Digisha Trivedi, Min You, Lisa Rosenblatt

J Med Econ· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records.
Marc B Rosenman, Layla Baker, Yonghua Jing, Dinara Makenbaeva, Brian Meissner

Curr Med Res Opin· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of anti-tumor necrosis factor agents in the treatment of rheumatoid arthritis: observational study.
Anna D'Souza, Brian L Meissner, Boxiong Tang, R Scott McKenzie, Catherine T Piech

Am Health Drug Benefits· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A United States cost-benefit comparison of an apodized, diffractive, presbyopia-correcting, multifocal intraocular lens and a conventional monofocal lens.
William A Maxwell, Curtis R Waycaster, Anna O D'Souza, Brian L Meissner, Kendra Hileman

J Cataract Refract Surg· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct economic effect following mupirocin therapy failure among patients with uncomplicated skin and skin-structure infections in a large population-based cohort.
Brian Meissner, Steven P Burch, Matt Sarnes, Chad Green, Marybeth Dalessandro

Manag Care Interface· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the impact of Medicare Part D implementation on the pharmacy workforce.
Brian Meissner, Donald Harrison, Jean Carter, Matthew Borrego

Res Social Adm Pharm· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization.
Brian Meissner, Michael Dickson, Judy Shinogle, C E Reeder, Dea Belazi

J Manag Care Pharm· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids.
Brian L Meissner, W Mark Moore, Judith A Shinogle, C E Reeder, John M Little

J Manag Care Pharm· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis